News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Pantarhei to Bid for Merck & Co., Inc.'s Organon Unit
February 14, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters) - Dutch bioscience company Pantarhei intends to bid for the bulk of U.S. company Merck's (MRK.N) Netherlands-based bioscience research unit Organan, the Dutch Financieele Dagblad reported on Monday.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
Merck & Co.
Organon
MORE ON THIS TOPIC
Mergers & acquisitions
Chiesi snaps up KalVista for $1.9B, betting big on rare disease med Ekterly
April 29, 2026
·
2 min read
·
Gabrielle Masson
Podcast
Q1 earnings take off, Lilly strikes many deals, Regeneron notches historic approval, FDA raises questions
April 29, 2026
·
1 min read
·
Heather McKenzie
Insights
Biotech angels lean into deeper diligence and disciplined early bets
April 29, 2026
·
4 min read
·
Jennifer C. Smith-Parker
Mergers & acquisitions
AbbVie sinks talons into KRAS with right to buy Kestrel for up to $1.45B
April 28, 2026
·
1 min read
·
Annalee Armstrong
